Erythropoietin-dependent transformation of myelodysplastic syndrome to acute monoblastic leukemia
Open Access
- 1 December 2001
- journal article
- case report
- Published by American Society of Hematology in Blood
- Vol. 98 (12) , 3492-3494
- https://doi.org/10.1182/blood.v98.12.3492
Abstract
Acute monoblastic leukemia (acute myeloid leukemia [AML], French-American-British type M5a) with leukemia cutis developed in a patient 6 weeks after the initiation of erythropoietin (EPO) therapy for refractory anemia with ringed sideroblasts. AML disappeared from both marrow and skin after the discontinuation of EPO. Multiparameter flow cytometric analysis of bone marrow cells demonstrated coexpression of the EPO receptor with CD45 and CD13 on the surface of blasts. The incubation of marrow cells with EPO, compared to without, resulted in 1.3- and 1.6-fold increases, respectively, in tritiated thymidine incorporation and bromodeoxyuridine incorporation into CD13+ cells. Clinical and laboratory findings were consistent with the EPO-dependent transformation of myelodysplastic syndrome (MDS) to AML. It is concluded that leukemic transformation in patients with MDS treated with EPO may be EPO-dependent and that management should consist of the discontinuation of EPO followed by observation, if clinically feasible.Keywords
This publication has 19 references indexed in Scilit:
- Quantitative expression of erythropoietin receptor (EPO‐R) on acute leukaemia cells: relationships between the amount of EPO‐R and CD phenotypes, in vitro proliferative response, the amount of other cytokine receptors and clinical prognosisBritish Journal of Haematology, 2000
- MyelodysplasiaNew England Journal of Medicine, 1999
- Transient Increase in Blasts Mimicking Acute Leukemia and Progressing Myelodysplasia in Patients Receiving Growth FactorAmerican Journal of Clinical Pathology, 1998
- Acute Leukemia in a Uremic Patient Undergoing Erythropoietin TreatmentNephron, 1997
- The use of r‐HuEpo in the treatment of anaemia related to myelodysplasia (MDS)British Journal of Haematology, 1995
- Efficacy of erythropoietin in the myelodysplastic syndromes: a meta‐analysis of 205 patients from 17 studiesBritish Journal of Haematology, 1995
- Acute Leukemia and Erythropoietin Cause or Casual Relationship?Nephron, 1995
- Recombinant Human Erythropoietin in Patients with Myelodysplastic Syndrome and MyelofibrosisActa Haematologica, 1993
- Identification of DNA-replicating lymphocyte subsets using a new method to label the bromo-deoxyuridine incorporated into the DNAJournal of Immunological Methods, 1992
- Enhanced growth of clonogenic cells from acute myeloblastic leukaemia by erythropoietinBritish Journal of Haematology, 1990